Crtc1缺失导致海马神经能量损伤并与抑郁样行为相关
该研究利用神经影像技术发现,小鼠Crtc1缺失产生与抑郁样行为相关的海马代谢损伤影像指纹。海马葡萄糖代谢缺陷被确定为标记的分子/生理起源,能量增强型情绪稳定剂ebselen可逆转行为与神经影像标记。结果提示GABA能系统是代谢障碍相关行为功能障碍的潜在治疗靶点。
要点
- Crtc1缺失小鼠呈现海马代谢损伤影像指纹与抑郁样行为。
- 海马葡萄糖代谢缺陷是影像标记的分子/生理起源。
- ebselen逆转行为与神经影像标记,GABA能系统为潜在靶点。
核心结论
- Crtc1缺失通过海马葡萄糖代谢缺陷导致抑郁样行为及相应神经影像标记。
- 能量增强型情绪稳定剂ebselen可逆转行为与神经影像标记。
- GABA能系统可能是代谢障碍相关行为功能障碍的潜在治疗靶点。
研究设计与样本
- 临床前小鼠模型研究,采用神经影像技术检测Crtc1缺失后的脑影像改变。
主要发现
- Crtc1缺失小鼠出现与抑郁样行为相关的海马代谢损伤影像指纹。
- 海马葡萄糖代谢缺陷被确定为影像标记的分子/生理起源。
- ebselen治疗逆转了小鼠行为与神经影像标记。
临床怎么用
- 提示海马葡萄糖代谢影像标记可能作为抑郁症相关临床潜力标记。
- 提示GABA能系统可作为代谢障碍相关行为功能障碍的治疗研究方向。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Mood disorders (MD) are a major burden on society as their biology remains poorly understood, challenging both diagnosis and therapy. Among many observed biological dysfunctions, homeostatic dysregulation, such as metabolic syndrome (MeS), shows considerable comorbidity with MD. Recently, CREB-regulated transcription coactivator 1 (CRTC1), a regulator of brain metabolism, was proposed as a promising factor to understand this relationship. Searching for imaging biomarkers and associating them with pathophysiological mechanisms using preclinical models can provide significant insight into these complex psychiatric diseases and help the development of personalized healthcare. Here, we used neuroimaging technologies to show that deletion of Crtc1 in mice leads to an imaging fingerprint of hippocampal metabolic impairment related to depressive-like behavior. By identifying a deficiency in hippocampal glucose metabolism as the underlying molecular/physiological origin of the markers, we could assign an energy-boosting mood-stabilizing treatment, ebselen, which rescued behavior and neuroimaging markers. Finally, our results point toward the GABAergic system as a potential therapeutic target for behavioral dysfunctions related to metabolic disorders. This study provides new insights on Crtc1's and MeS's relationship to MD and establishes depression-related markers with clinical potential.
引用
- Cherix A, Poitry-Yamate C, Lanz B, et al. Deletion of Crtc1 leads to hippocampal neuroenergetic impairments associated with depressive-like behavior. Mol Psychiatry. 2022. PMID: 36224260. doi:10.1038/s41380-022-01791-5
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。